Processa Pharmaceuticals (PCSA) Short Interest Ratio & Short Volume

+0.07 (+4.58%)
(As of 04/23/2024 ET)

Processa Pharmaceuticals Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
Short Interest Ratio / Days to Cover
Last Record Date
March 31, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Processa Pharmaceuticals ?

Sign up to receive the latest short interest report for Processa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PCSA Short Interest Over Time

PCSA Days to Cover Over Time

PCSA Percentage of Float Shorted Over Time

Processa Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202435,800 shares $84,667.00 -11.2%1.6%0 $2.37
3/15/202440,300 shares $88,257.00 -40.1%2.9%0 $2.19
2/29/202467,300 shares $165,558.00 -29.7%5.4%0 $2.46
2/15/202495,700 shares $232,551.00 -41.0%7.7%0.1 $2.43
1/31/2024162,100 shares $382,556.00 +1,721.4%12.5%0.1 $2.36
1/15/20248,900 shares $46,796.20 -98.0%0.7%0.1 $5.26
12/31/2023443,300 shares $148,328.18 +46.3%N/A0.2 $0.33
12/15/2023303,000 shares $216,645.00 -17.6%N/A0.1 $0.72
11/30/2023367,800 shares $235,392.00 +55.1%N/A0.2 $0.64
11/15/2023237,200 shares $93,456.80 +13.6%N/A0.1 $0.39
10/31/2023208,900 shares $73,323.90 +13.0%N/A0.1 $0.35
10/15/2023184,800 shares $88,704.00 +43.4%N/A0.1 $0.48
9/30/2023128,900 shares $32,250.78 -6.7%N/A1.2 $0.25
9/15/2023138,100 shares $53,168.50 +14.9%N/A1.8 $0.39
8/31/2023120,200 shares $37,742.80 +31.8%N/A1 $0.31
8/15/202391,200 shares $34,656.00 +11.6%N/A0.8 $0.38
7/31/202381,700 shares $35,948.00 -6.6%N/A0.7 $0.44
7/15/202387,500 shares $40,512.50 -28.7%N/A0.7 $0.46
6/30/2023122,700 shares $61,043.25 -32.6%N/A1 $0.50
6/15/2023182,000 shares $109,200.00 -9.6%N/A1.6 $0.60
5/31/2023201,300 shares $124,806.00 +3.2%N/A2.3 $0.62
5/15/2023195,000 shares $128,505.00 +0.5%N/A2.1 $0.66
4/30/2023194,000 shares $122,220.00 +18.7%N/A1.6 $0.63
4/15/2023163,500 shares $81,750.00 -12.3%N/A0.6 $0.50
3/31/2023186,400 shares $93,218.64 -41.7%N/A0.7 $0.50
3/15/2023319,700 shares $164,325.80 -14.3%N/A1.2 $0.51
2/28/2023372,900 shares $249,805.71 -15.8%N/A1.4 $0.67
2/15/2023442,800 shares $352,026.00 +94.5%N/A1.7 $0.80
1/31/2023227,700 shares $194,683.50 -1.6%2.0%0.9 $0.86
1/15/2023231,500 shares $289,375.00 -9.3%2.0%5.2 $1.25
12/30/2022255,300 shares $280,830.00 +124.7%2.2%6.3 $1.10
12/15/2022113,600 shares $214,704.00 +38.4%1.0%3 $1.89
11/30/202282,100 shares $155,948.95 +11.7%0.7%4.3 $1.90
11/15/202273,500 shares $151,410.00 -5.3%0.7%4.3 $2.06
10/31/202277,600 shares $164,512.00 +7.0%0.7%5.5 $2.12
10/15/202272,500 shares $160,950.00 -13.3%0.7%5.6 $2.22
9/30/202283,600 shares $188,936.00 +27.3%0.8%6.6 $2.26
9/15/202265,700 shares $170,820.00 +0.2%0.6%4.6 $2.60
8/31/202265,600 shares $180,400.00 -4.8%0.6%4.5 $2.75
8/15/202268,900 shares $224,614.00 -4.8%0.6%4.3 $3.26
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

PCSA Short Interest - Frequently Asked Questions

What is Processa Pharmaceuticals' current short interest?

Short interest is the volume of Processa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 35,800 shares of PCSA short. 1.56% of Processa Pharmaceuticals' shares are currently sold short. Learn More on Processa Pharmaceuticals' current short interest.

What is a good short interest percentage for Processa Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.56% of Processa Pharmaceuticals' floating shares are currently sold short.

Is Processa Pharmaceuticals' short interest increasing or decreasing?

Processa Pharmaceuticals saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 35,800 shares, a drop of 11.2% from the previous total of 40,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Processa Pharmaceuticals' float size?

Processa Pharmaceuticals currently has issued a total of 2,860,000 shares. Some of Processa Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Processa Pharmaceuticals currently has a public float of 2,290,000 shares.

How does Processa Pharmaceuticals' short interest compare to its competitors?

1.56% of Processa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Processa Pharmaceuticals: Genprex, Inc. (3.78%), ZyVersa Therapeutics, Inc. (8.09%), Tharimmune, Inc. (0.65%), Lipella Pharmaceuticals Inc. (1.24%), Kintara Therapeutics, Inc. (1.69%), Artelo Biosciences, Inc. (0.45%), Ensysce Biosciences, Inc. (0.60%), Biophytis S.A. (0.73%), Virpax Pharmaceuticals, Inc. (3.42%), Cingulate Inc. (1.21%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Processa Pharmaceuticals stock?

Short selling PCSA is an investing strategy that aims to generate trading profit from Processa Pharmaceuticals as its price is falling. PCSA shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Processa Pharmaceuticals?

A short squeeze for Processa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCSA, which in turn drives the price of the stock up even further.

How often is Processa Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCSA, twice per month. The most recent reporting period available is March, 31 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:PCSA) was last updated on 4/23/2024 by Staff

From Our Partners